Table 1: General characteristics of patients enrolled in the study

Criteria		Total No. (28 cases)	(Gem-Ox) (12 cases)	(Gem-Ox-Pem) (16 cases)	P Value
Gender
	Male	23 (82.1%)	10 (83.3%)	13 (81.3%)	0.64
	Female	5 (17.9%)	2 (16.7%)	3 (18.8%)	0.38
Stage
	III-B	12 (42.9%)	5 (41.7%)	7 (43.8%)	0.3
	IV	16 (57.1%)	7 (58.3%)	9 (56.3%)	0.61
Elevated Biochemical marker
	SGOT	5 (17.9%)	1 (8.3%)	4 (25%)	0.22
	Hypercalcemia	9 (32.1%)	3 (25%)	6 (37.5%)	0.26
	Alkaline phosphatase	11 (39.3%)	5 (41.7%)	6 (37.5%)	0.3
Pathological Types
	Adenocarcinoma	18 (64.3%)	8 (66.7%)	10 (62.5%)	0.57
	Large cell	10 (35.7%)	4 (33.3%)	6 (37.5%)	0.3

Gem indicates gemcitabine ; Ox, oxaliplatin; Pem, pemetrexed.